Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral tablet for oral use. It is prescribed for cognitive impairment, age‑related memory decline, post‑stroke recovery, vertigo, myoclonus, and learning difficulties in adults. The compound modulates neuronal membrane fluidity and may enhance neurotransmitter activity, supporting cognitive processes.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers, including batch release certificates and stability data.

Piracetam is used as a cognitive enhancer and neuroprotective agent in several neurological conditions.

Cognitive impairment and dementia: improves memory function and learning capacity in affected individuals. Age‑related memory decline: helps maintain short‑term recall and attention in older adults. Post‑stroke recovery: supports rehabilitation by enhancing neuroplasticity and motor learning after cerebral ischemia. Vertigo and balance disorders: reduces frequency of vertiginous episodes and improves equilibrium. Myoclonus: decreases involuntary muscle jerks and improves motor control. Dyslexia and learning difficulties: facilitates information processing and reading skills in patients with learning disorders.

Piracetam is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Insomnia: difficulty initiating sleep. - Anxiety: increased nervousness or restlessness. - Dizziness: transient light‑headedness. - Gastrointestinal discomfort: abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Skin rash: hypersensitivity reactions including erythema. - Allergic reactions: angioedema or anaphylaxis in rare cases. - Blood disorders: thrombocytopenia or leukopenia reported infrequently. - Severe depression: emergence of mood disturbances. - Seizures: rare occurrence, especially in predisposed individuals.

When prescribing piracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal function: assess and adjust use in patients with severe renal impairment. - Elderly patients: monitor for confusion or worsening cognition. - Pregnancy: safety category unknown; avoid unless potential benefit justifies risk. - Concomitant anticoagulants: observe for increased bleeding tendency. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Piracetam may interact with other medicines, requiring attention to potential pharmacodynamic or pharmacokinetic effects.

Major Interactions (Avoid): - Anticoagulants: may enhance anticoagulant effect and increase bleeding risk. - Anticonvulsants: can reduce the efficacy of seizure‑control medications. - Alcohol: may potentiate central nervous system depression.

Moderate Interactions (Monitor Closely): - Caffeine: combined use may increase nervousness or insomnia. - Diuretics: may alter plasma concentrations of piracetam.